Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brock T Shireman

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
ACS Medicinal Chemistry Letters|April 17, 2024
Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian DisruptionsStefan McCarver, Luke Hanna, Andrew Samant, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793Cathy Préville, Pascal Bonaventure, Tatiana Koudriakova, et al.
Journal of Medicinal Chemistry|June 19, 2015
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical CandidateMichael A Letavic, Pascal Bonaventure, Nicholas I Carruthers, et al.
Translational Psychiatry|September 8, 2020
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humansGiacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2023
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)Jocelyn Wang, Kohki M Nakafuku, Jeannie Ziff, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2DAaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
ACS Medicinal Chemistry Letters|April 17, 2024
Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian DisruptionsStefan McCarver, Luke Hanna, Andrew Samant, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Substituted Azabicyclo[2.2.1]heptanes as Selective Orexin-1 Antagonists: Discovery of JNJ-54717793Cathy Préville, Pascal Bonaventure, Tatiana Koudriakova, et al.
Journal of Medicinal Chemistry|June 19, 2015
Novel Octahydropyrrolo[3,4-c]pyrroles Are Selective Orexin-2 Antagonists: SAR Leading to a Clinical CandidateMichael A Letavic, Pascal Bonaventure, Nicholas I Carruthers, et al.
Translational Psychiatry|September 8, 2020
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humansGiacomo Salvadore, Pascal Bonaventure, Anantha Shekhar, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2023
Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)Jocelyn Wang, Kohki M Nakafuku, Jeannie Ziff, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2023
Identification of small-molecule protein-protein interaction inhibitors for NKG2DAaron A Thompson, Michael B Harbut, Pei-Pei Kung, et al.
Pageof 2